1
|
Kuan EC, Talati V, Patel JA, Nguyen TV, Abiri A, Pang JC, Goshtasbi K, Liu L, Craig JR, Papagiannopoulos P, Phillips KM, Tajudeen BA, Adappa ND, Palmer JN, Sedaghat AR, Wang EW, Anand V, Batra PS, Bergsneider M, Bernal-Sprekelsen M, Bleier BS, Cappabianca P, Carrau RL, Casiano RR, Castelnuovo P, Cavallo LM, Cohen MA, Dallan I, Eloy JA, El-Sayed IH, Evans JJ, Fernandez-Miranda JC, Ferrari M, Froelich S, Gardner PA, Georgalas C, Gray ST, Hanna EY, Harvey RJ, Hong SD, Hwang PH, Kelly DF, Kong DS, Lan MY, Lee JYK, Levine CG, Liu JK, Locatelli D, Meço C, McKean EL, Nicolai P, Nyquist GG, Omura K, Passeri T, Patel ZM, Celda MP, Neto CP, Rabinowitz MR, Rabinowitz MR, Raza SM, Recinos PF, Rosen MR, Sargi ZB, Schlosser RJ, Schwartz TH, Sindwani R, Snyderman CH, Stamm AC, Thorp BD, Turri-Zanoni M, Wang MB, Wang WH, Witterick IJ, Won TB, Woodworth BA, Wormald PJ, Zada G, Su SY. Expert Strategies: Skull Base Reconstruction-Global Perspectives, Insights, and Algorithms through a MixedMethods Approach. Int Forum Allergy Rhinol 2025:e23596. [PMID: 40371737 DOI: 10.1002/alr.23596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2025] [Revised: 04/02/2025] [Accepted: 04/03/2025] [Indexed: 05/16/2025]
Abstract
OBJECTIVE There is limited consensus on endoscopic skull base surgery (ESBS) reconstruction principles. This study aims to generate comprehensive themes regarding ESBS reconstruction by pooling the experiences of ESBS experts, with comparison to a literature review of current published evidence. METHODS Structured qualitative interviews of ESBS experts regarding postoperative management and reconstruction of various defect locations were conducted. RESULTS A total of 68 experts comprising 40 academic teams across 13 countries with an average of 18 years of ESBS experience were included. We propose 10 stepwise algorithms for common skull base reconstruction scenarios based on these expert interviews. When available, the nasoseptal flap is used for all high_flow cerebrospinal leak defects. Multilayered reconstruction is favored at all anatomical subsites with increasing number of layers for increasing defect size and complexity. Heterogeneity exists in terms of inlay technique and materials, free grafting versus various pedicled flap options for low-flow defects or in the absence of a nasal septum, nasal packing, tissue sealant, lumbar drain use, and postoperative management. Commonalities and discrepancies between experts were summarized. CONCLUSION Skull base reconstruction and post-ESBS management is highly complex with a wide variety of practice patterns and expert strategies. Further research of higher quality evidence is warranted to identify optimal management patterns, though the current work aims to inform surgeons on these controversial areas by drawing from numerous experiences.
Collapse
Affiliation(s)
- Edward C Kuan
- Departments of Otolaryngology, Head and Neck Surgery and Neurological Surgery, University of California, Irvine, Orange, California, USA
| | - Vidit Talati
- Department of Otorhinolaryngology, Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, USA
| | - Jagatkumar A Patel
- Kaiser Permanente, Orange County, Anaheim, California, USA
- Walter Reed National Military Medical Center, Bethesda, Maryland, USA
| | - Theodore V Nguyen
- Department of Otolaryngology, Head and Neck Surgery, University of California, Irvine, Orange, California, USA
| | - Arash Abiri
- Department of Otolaryngology, Head and Neck Surgery, University of California, Irvine, Orange, California, USA
| | - Jonathan C Pang
- Department of Otolaryngology, Head and Neck Surgery, University of California, Irvine, Orange, California, USA
| | - Khodayar Goshtasbi
- Department of Otolaryngology, Head and Neck Surgery, University of California, Irvine, Orange, California, USA
| | - Lauren Liu
- Department of Otolaryngology, Head and Neck Surgery, University of California, Irvine, Orange, California, USA
| | - John R Craig
- Department of Otolaryngology, Head and Neck Surgery, Henry Ford Health, Detroit, Michigan, USA
| | - Peter Papagiannopoulos
- Department of Otorhinolaryngology, Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, USA
| | - Katie M Phillips
- Department of Otolaryngology, Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
| | - Bobby A Tajudeen
- Department of Otorhinolaryngology, Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, USA
| | - Nithin D Adappa
- Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA
| | - James N Palmer
- Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA
| | - Ahmad R Sedaghat
- Department of Otolaryngology, Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
| | - Eric W Wang
- Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
| | - Vijay Anand
- Department of Otolaryngology, Head and Neck Surgery, New York-Presbyterian/Cornell University, Weill Cornell Medical College, New York, New York, USA
| | - Pete S Batra
- Department of Otorhinolaryngology, Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, USA
| | - Marvin Bergsneider
- Department of Neurosurgery, University of California Los Angeles, Los Angeles, California, USA
| | - Manuel Bernal-Sprekelsen
- Otorhinolaryngology Department, Surgery and Medical-Surgical Specialties Department, Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain
| | - Benjamin S Bleier
- Department of Otolaryngology, Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA
| | - Paolo Cappabianca
- Department of Neurosurgery, Federico II University Hospital, Naples, Italy
| | - Ricardo L Carrau
- Department of Otolaryngology, Head and Neck Surgery, The Ohio State University, Columbus, Ohio, USA
| | - Roy R Casiano
- Department of Otolaryngology, Head and Neck Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Paolo Castelnuovo
- Department of Biotechnology and Life Sciences, Division of Otorhinolaryngology, University of Insubria, ASST Sette Laghi Hospital, Varese, Italy
| | - Luigi M Cavallo
- Department of Neurosurgery, Federico II University Hospital, Naples, Italy
| | - Marc A Cohen
- Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
| | - Iacopo Dallan
- Department of Otolaryngology, Head and Neck Surgery, Pisa University Hospital, Pisa, Italy
| | - Jean Anderson Eloy
- Department of Otolaryngology, Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA
| | - Ivan H El-Sayed
- Department of Otolaryngology, Head and Neck Surgery, University of California, San Francisco, San Francisco, California, USA
| | - James J Evans
- Department of Neurological Surgery and Otolaryngology, Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Juan C Fernandez-Miranda
- Department of Neurological Surgery, Stanford University School of Medicine, Palo Alto, California, USA
| | - Marco Ferrari
- Department of Neurosciences, Section of Otorhinolaryngology, Head and Neck Surgery, University of Padova, Padova, Italy
| | - Sebastien Froelich
- Department of Neurosurgery, Lariboisière Hospital, University of Paris Diderot, Paris, France
| | - Paul A Gardner
- Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
| | - Christos Georgalas
- Department of Otorhinolaryngology, Head and Neck Surgery, University of Nicosia Medical School, Nicosia, Cyprus
| | - Stacey T Gray
- Department of Otolaryngology, Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA
| | - Ehab Y Hanna
- Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Richard J Harvey
- Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of South Wales, Sydney, NSW, Australia
| | - Sang Duk Hong
- Department of Otorhinolaryngology, Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Peter H Hwang
- Department of Otolaryngology, Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, USA
| | - Daniel F Kelly
- Department of Neurosurgery, Pacific Neuroscience Institute, Santa Monica, California, USA
| | - Doo-Sik Kong
- Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Ming-Ying Lan
- Department of Otorhinolaryngology, Head and Neck Surgery, Taipei Veterans General Hospital, Taipei, Taiwan
| | - John Y K Lee
- Department of Neurosurgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA
| | - Corinna G Levine
- Department of Otolaryngology, Head and Neck Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
| | - James K Liu
- Department of Neurological Surgery, New Jersey Medical School, Newark, New Jersey, USA
| | - Davide Locatelli
- Department of Biotechnology and Life Sciences, Division of Neurological Surgery, University of Insubria, ASST Sette Laghi Hospital, Varese, Italy
| | - Cem Meço
- Department of Surgery, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA
- Department of Otorhinolaryngology, Head and Neck Surgery, Ankara University Medical School, Ankara, Turkey
- Department of Otorhinolaryngology, Head and Neck Surgery, Salzburg Paracelsus Medical University, Salzburg, Austria
| | - Erin L McKean
- Department of Otolaryngology, Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA
| | - Piero Nicolai
- Department of Neurosciences, Section of Otorhinolaryngology, Head and Neck Surgery, University of Padova, Padova, Italy
| | - Gurston G Nyquist
- Department of Otolaryngology, Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Kazuhiro Omura
- Department of Otorhinolaryngology, The Jikei University School of Medicine, Tokyo, Japan
| | - Thibault Passeri
- Department of Neurosurgery, Lariboisière Hospital, University of Paris Diderot, Paris, France
| | - Zara M Patel
- Department of Otolaryngology, Head and Neck Surgery, Stanford University School of Medicine, Stanford, California, USA
| | - Maria Peris Celda
- Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota, USA
| | - Carlos Pinheiro Neto
- Department of Otolaryngology, Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA
| | - Mindy R Rabinowitz
- Department of Neurological Surgery, The Ohio State University, Columbus, Ohio, USA
| | - Mindy R Rabinowitz
- Department of Otolaryngology, Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Shaan M Raza
- Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
| | - Pablo F Recinos
- Department of Neurological Surgery, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
| | - Marc R Rosen
- Department of Otolaryngology, Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Zoukaa B Sargi
- Department of Otolaryngology, Head and Neck Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Rodney J Schlosser
- Department of Otolaryngology, Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA
| | - Theodore H Schwartz
- Department of Neurological Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA
| | - Raj Sindwani
- Head and Neck Institute, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio, USA
| | - Carl H Snyderman
- Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
| | - Aldo C Stamm
- São Paulo ENT Center (COF), Edmundo Vasconcelos Complex, São Paulo, Brazil
| | - Brian D Thorp
- Department of Otolaryngology, Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
| | - Mario Turri-Zanoni
- Department of Biotechnology and Life Sciences, Division of Otorhinolaryngology, University of Insubria, ASST Sette Laghi Hospital, Varese, Italy
| | - Marilene B Wang
- Department of Otolaryngology, Head and Neck Surgery, University of California Los Angeles, Los Angeles, California, USA
| | - Wei-Hsin Wang
- Division of General Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan
| | - Ian J Witterick
- Department of Otolaryngology, Head and Neck Surgery, University of Toronto, Toronto, ON, Canada
| | - Tae-Bin Won
- Department of Otorhinolaryngology, Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea
| | - Bradford A Woodworth
- Department of Otolaryngology, Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Peter-John Wormald
- Department of Otolaryngology, Head and Neck Surgery, Queen Elizabeth Hospital, Adelaide, SA, Australia
| | - Gabriel Zada
- Department of Neurosurgery, University of Southern California, Los Angeles, California, USA
| | - Shirley Y Su
- Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| |
Collapse
|
2
|
Snyder R, Rubino F, Seaman S, Banu M, Su SY, Hanna EY, DeMonte F, Raza SM. Impact of Previous Surgery and/or Radiation Therapy on Endoscopic Reconstruction Outcomes. Oper Neurosurg (Hagerstown) 2025; 28:496-505. [PMID: 39185868 DOI: 10.1227/ons.0000000000001318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2024] [Accepted: 07/04/2024] [Indexed: 08/27/2024] Open
Abstract
BACKGROUND AND OBJECTIVES The impact of prior local therapies, including radiation and surgery, on reconstruction outcomes after endonasal surgery is currently not well known. Reconstruction nuances in the preoperative setting merit further evaluation to avoid potential postoperative complications that can hinder overall tumor management and negatively impact patient outcome. We sought to determine whether prior treatments increase risk of reconstruction-related postoperative morbidity and to evaluate the effectiveness of our current treatment paradigm for skull base reconstruction. METHODS A retrospective review of all endonasal surgeries for tumor resection between March 2000 and March 2022 was performed. Patients were grouped based on treatment history. Patient demographics, operative, and postoperative reconstruction-related morbidity data were collected, including cerebrospinal fluid leak, sinonasal morbidity, and infectious complications. Variables significantly associated with postoperative complications in the univariate analysis were included in the multivariate Cox proportional hazards regression model. Complication-free survival curves were generated, and the log-rank test evaluated the relationship between complication-free survival and the different clinical, surgical, and treatment parameters. All statistical analyses were performed with SPSS 26 (IBM Corp) and Graph Pad 9.0 (GraphPad Software). RESULTS A total of 418 patients were included. 291 patients had no prior treatments, 49 patients had previously received radiation, and 78 patients had prior surgeries. Of the 49 patients who had prior radiation, 27% underwent reconstruction with tunneled pericranial flaps vs 16% of treatment-naïve patients. On multivariate analysis, prior treatment was not significantly associated with reconstruction-related complications. Negative smoking history, no leak or small intraoperative leak, and use of vascularized flap in reconstruction were protective factors. CONCLUSION In patients undergoing endonasal surgery, prior radiation and/or surgery does not appear to significantly increase the risk of immediate or delayed reconstruction complications using our current reconstructive management plan, which incorporates an upfront regional flap for high-risk cases.
Collapse
Affiliation(s)
- Rita Snyder
- Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston , Texas , USA
| | - Franco Rubino
- Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston , Texas , USA
| | - Scott Seaman
- Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston , Texas , USA
| | - Matei Banu
- Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston , Texas , USA
| | - Shirley Y Su
- Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston , Texas , USA
| | - Ehab Y Hanna
- Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston , Texas , USA
| | - Franco DeMonte
- Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston , Texas , USA
| | - Shaan M Raza
- Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston , Texas , USA
| |
Collapse
|
3
|
Cuny T, Reynaud R, Raverot G, Coutant R, Chanson P, Kariyawasam D, Poitou C, Thomas-Teinturier C, Baussart B, Samara-Boustani D, Feuvret L, Villanueva C, Villa C, Bouillet B, Tauber M, Espiard S, Castets S, Beckers A, Amsellem J, Vantyghem MC, Delemer B, Chevalier N, Brue T, André N, Kerlan V, Graillon T, Raingeard I, Alapetite C, Raverot V, Salenave S, Boulin A, Appay R, Dalmas F, Fodil S, Coppin L, Buffet C, Thuillier P, Castinetti F, Vogin G, Cazabat L, Kuhn E, Haissaguerre M, Reznik Y, Goichot B, Bachelot A, Kamenicky P, Decoudier B, Planchon C, Micoulaud-Franchi JA, Romanet P, Jacobi D, Faucher P, Carette C, Bihan H, Drui D, Rossignol S, Gonin L, Sokol E, Wiard L, Courtillot C, Nicolino M, Grunenwald S, Chabre O, Christin-Maître S, Desailloud R, Maiter D, Guignat L, Brac de la Perrière A, Salva P, Scavarda D, Bonneville F, Caron P, Vasiljevic A, Leclercq D, Cortet C, Gaillard S, Albarel F, Clément K, Jouanneau E, Dufour H, Barat P, Gatta-Cherifi B. Diagnosis and management of children and adult craniopharyngiomas: A French Endocrine Society/French Society for Paediatric Endocrinology & Diabetes Consensus Statement. ANNALES D'ENDOCRINOLOGIE 2025; 86:101631. [PMID: 39002896 DOI: 10.1016/j.ando.2024.07.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/16/2024] [Accepted: 07/07/2024] [Indexed: 07/15/2024]
Affiliation(s)
- Thomas Cuny
- AP-HM, Department of Endocrinology, Hôpital de la Conception, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Aix-Marseille Université, Inserm, U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), 13005 Marseille, France.
| | - Rachel Reynaud
- AP-HM, Multidisciplinary Pediatrics Department, Hôpital de la Timone, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Aix-Marseille Université, Inserm, U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), 13005 Marseille, France
| | - Gérald Raverot
- Department of Endocrinology, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, "Groupement Hospitalier Est" Hospices Civils de Lyon, Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Claude-Bernard Lyon 1 University, Lyon, France
| | - Régis Coutant
- Department of Paediatric Endocrinology, Angers University Hospital, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Angers, France
| | - Philippe Chanson
- Inserm, Université Paris-Saclay, Physiologie et Physiopathologie Endocriniennes, AP-HP, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, 94270 Le Kremlin-Bicêtre, France
| | - Dulanjalee Kariyawasam
- Service d'Endocrinologie, Diabétologie, Gynécologie pédiatriques, Hôpital Universitaire Necker-Enfants-Malades, AP-HP Centre, Université Paris Cité, Paris, France
| | - Christine Poitou
- Service de Nutrition, hôpital de la Pitié-Salpêtrière, AP-HP, Sorbonne Université, Inserm, Unité Nutrition et Obésités, approches systémiques, Nutriomique, 75013 Paris, France
| | - Cécile Thomas-Teinturier
- Université Paris-Saclay, Radiation Epidemiology Team, Inserm U1018, AP-HP, Hôpital Bicêtre, Department of Pediatric Endocrinology and Diabetes, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Le Kremlin-Bicêtre, France
| | - Bertrand Baussart
- Department of Neurosurgery, AP-HP, La Pitié-Salpêtrière University Hospital, Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France
| | - Dinane Samara-Boustani
- Department of Paediatric Endocrinology, Diabetology, Gynaecology, Necker-Enfants-Malades University Hospital, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement, Centre de référence des Pathologies Gynécologiques Rares, AP-HP Centre, 75015 Paris, France
| | - Loïc Feuvret
- Department of Radiotherapy and Neuroradiosurgery, "Groupement Hospitalier Est" Hospices Civils de Lyon, Bron, France
| | - Carine Villanueva
- Department of Paediatric Endocrinology, Centre de Référence des Maladies Rares de l'hypophyse HYPO, "Groupement Hospitalier Est" Hospices Civils de Lyon, Faculty of Medicine, Claude-Bernard Lyon 1 University, Bron, France
| | - Chiara Villa
- Department of Neuropathology, AP-HP, La Pitié-Salpêtrière University Hospital, Inserm U1016, Institut Cochin, CNRS UMR 8104, Université Paris Descartes-Université de Paris, Paris, France
| | - Benjamin Bouillet
- Department of Endocrinology, Diabetes and Metabolic Disorders, Dijon University Hospital, Inserm Unit, LNC-UMR 1231, University of Burgundy, Dijon, France
| | - Maïthé Tauber
- Centre de Référence du Syndrome de Prader-Willi et autres syndromes avec troubles du comportement alimentaire, Hôpital des Enfants, CHU de Toulouse, Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity) Inserm UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse, France
| | - Stéphanie Espiard
- University of Lille, CHU de Lille, Department of Endocrinology, Diabetology, and Metabolism, U1190 Translational Research for Diabetes, Inserm, Institut Pasteur de Lille, Lille, France
| | - Sarah Castets
- AP-HM, Multidisciplinary Pediatrics Department, Hôpital de la Timone, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Aix-Marseille Université, Inserm, U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), 13005 Marseille, France
| | - Albert Beckers
- Department of Endocrinology, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium
| | - Jessica Amsellem
- Department of Paediatric Endocrinology, Angers University Hospital, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Angers, France
| | - Marie-Christine Vantyghem
- University of Lille, CHU de Lille, Department of Endocrinology, Diabetology, and Metabolism, U1190 Translational Research for Diabetes, Inserm, Institut Pasteur de Lille, Lille, France
| | - Brigitte Delemer
- Department of Endocrinology, Diabetes and Nutrition, CHU de Reims, Hôpital Robert-Debré, 51100 Reims, France
| | | | - Thierry Brue
- AP-HM, Department of Endocrinology, Hôpital de la Conception, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Aix-Marseille Université, Inserm, U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), 13005 Marseille, France
| | - Nicolas André
- Marseille-La Timone University Hospital, Oncologie Pédiatrique, REMAP4KIDS CRCM Inserm U1068 Aix-Marseille University, Marseille, France
| | - Véronique Kerlan
- Department of Endocrinology, University Hospital, UMR Inserm 1304 GETBO, Brest, France
| | - Thomas Graillon
- Aix-Marseille Université, Inserm, AP-HM, MMG, UMR1251, Marmara Institute, La Timone Hospital, Hospital, Neurosurgery Department, Marseille, France
| | - Isabelle Raingeard
- Department of Endocrinology, University of Montpellier, Montpellier, France
| | - Claire Alapetite
- Institut Curie, Radiation Oncology Department, Paris & Proton Center, Orsay, France
| | - Véronique Raverot
- LBMMS, Laboratoire de Biochimie et biologie moléculaire, Hospices Civils de Lyon, 69677 Lyon, France
| | - Sylvie Salenave
- Inserm, Université Paris-Saclay, Physiologie et Physiopathologie Endocriniennes, AP-HP, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, 94270 Le Kremlin-Bicêtre, France
| | - Anne Boulin
- Department of Therapeutic and Interventional Neuroradiology, Hospital Foch, Suresnes, France
| | - Romain Appay
- AP-HM, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Aix-Marseille Université, CNRS, Inst Neurophysiopathol (INP), Marseille, France
| | - Florian Dalmas
- Department of Ophthalmology, Hôpital Nord, AP-HM, Marseille, France
| | - Sarah Fodil
- Department of Endocrinology, University of Montpellier, Montpellier, France
| | - Lucie Coppin
- Université de Lille, CNRS, Inserm, CHU de Lille, UMR9020-U1277 - Cancer - Heterogeneity Plasticity and Resistance to Therapies (CANTHER), Lille, France
| | - Camille Buffet
- Thyroid and Endocrine Tumors Department, Pitié-Salpêtrière Hospital, Thyroid Tumors Clinical Research Group, Sorbonne University, Cancer Institute, Inserm U1146, CNRS UMR 7371, Paris, France
| | - Philippe Thuillier
- Department of Endocrinology, University Hospital, UMR Inserm 1304 GETBO, Brest, France
| | - Frédéric Castinetti
- AP-HM, Department of Endocrinology, Hôpital de la Conception, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Aix-Marseille Université, Inserm, U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), 13005 Marseille, France
| | - Guillaume Vogin
- Centre François Baclesse, Centre national de radiothérapie du Luxembourg, Université de Luxembourg, Luxembourg Institute of Health, Luxembourg, Luxembourg
| | - Laure Cazabat
- UMR 1198 BREED, équipe RHuMA, UFR Simone Veil Santé, Université Versailles Saint-Quentin-en-Yvelines, Université Paris Saclay, Service de Neurochirurgie, Hôpital Foch, Suresnes, France
| | - Emmanuelle Kuhn
- Pituitary Unit, Hôpital Pitié-Salpêtrière, AP-HP, 75013 Paris, France
| | - Magalie Haissaguerre
- Department of Endocrinology, CHU Bordeaux, Hôpital Haut Lévêque, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, Université de Bordeaux, Pessac, France
| | - Yves Reznik
- Department of Endocrinology, Diabetes, Metabolic Disorders, University Hospital Caen, Caen, France
| | - Bernard Goichot
- Service d'Endocrinologie, Diabétologie et Nutrition, Hôpitaux Universitaires de Strasbourg, 67098 Strasbourg cedex, France
| | - Anne Bachelot
- AP-HP, Pitié-Salpêtrière Hospital, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du développement, Centre de Référence des Pathologies Gynécologiques Rares, Department of Endocrinology and Reproductive Medicine, Sorbonne Université Médecine, Paris, France
| | - Peter Kamenicky
- Inserm, Université Paris-Saclay, Physiologie et Physiopathologie Endocriniennes, AP-HP, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, 94270 Le Kremlin-Bicêtre, France
| | - Bénédicte Decoudier
- Department of Endocrinology, Diabetes and Nutrition, CHU de Reims, Hôpital Robert-Debré, 51100 Reims, France
| | - Charlotte Planchon
- Neurosurgery Department A, University Hospital of Bordeaux, place Amélie-Raba-Léon, Bordeaux, France
| | - Jean-Arthur Micoulaud-Franchi
- Sleep Medicine Unit, University Hospital of Bordeaux, UMR CNRS 6033 SANPSY, University Hospital of Bordeaux, 33076 Bordeaux, France
| | - Pauline Romanet
- Aix-Marseille Université, AP-HM, Inserm, MMG, La Timone Hospital, Laboratory of molecular biology GEnOPé, Marseille, France
| | - David Jacobi
- Nantes Université, CHU de Nantes, CNRS, Inserm, L'institut du Thorax, 44000 Nantes, France
| | - Pauline Faucher
- Service de Nutrition, hôpital de la Pitié-Salpêtrière, AP-HP, Sorbonne Université, Inserm, Unité Nutrition et Obésités, approches systémiques, Nutriomique, 75013 Paris, France
| | - Claire Carette
- Nutrition Department, Georges-Pompidou Hospital, AP-HP, Paris Cité University, Paris, France
| | - Hélène Bihan
- Avicenne Hospital, Bobigny, France; Health Education and Practices Laboratory, Université Paris 13, Paris, France
| | - Delphine Drui
- Service d'endocrinologie, diabétologie et nutrition, l'institut du thorax, Nantes université, CHU de Nantes, 44000 Nantes, France
| | - Sylvie Rossignol
- Department of Paediatric Endocrinology, University Hospital of Strasbourg, Strasbourg, France
| | - Lucile Gonin
- Department of dietetics, Hôpital de la Conception, Centre de Référence des Maladies Rares de l'hypophyse HYPO, Aix-Marseille Université, Marseille, France
| | | | - Laurent Wiard
- Dispositifs UEROS/CLANA, USN Tastet Girard, CHU de Bordeaux, Bordeaux, France
| | - Carine Courtillot
- AP-HP, Pitié-Salpêtrière Hospital, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du développement, Centre de Référence des Pathologies Gynécologiques Rares, Department of Endocrinology and Reproductive Medicine, Sorbonne Université Médecine, Paris, France
| | - Marc Nicolino
- Department of Paediatric Endocrinology, Centre de Référence des Maladies Rares de l'hypophyse HYPO, "Groupement Hospitalier Est" Hospices Civils de Lyon, Faculty of Medicine, Claude-Bernard Lyon 1 University, Bron, France
| | - Solange Grunenwald
- Department of Endocrinology, Hôpital Larrey, CHU de Toulouse, 31059 Toulouse cedex 9, France
| | - Olivier Chabre
- Université Grenoble Alpes, UMR 1292 Inserm-CEA-UGA, Endocrinologie CHU Grenoble-Alpes, 38000 Grenoble, France
| | - Sophie Christin-Maître
- Sorbonne University, Department of Endocrinology, Diabetes and Reproductive Medicine, Hôpital Saint-Antoine, Center of rare diseases Endo-ERN, AP-HP, Paris, France
| | - Rachel Desailloud
- Service d'Endocrinologie-Diabétologie-Nutrition, CHUAP, Peritox_I01, UPJV/INeris, 80000 Amiens, France
| | - Dominique Maiter
- Department of Endocrinology and Nutrition, UCLouvain Cliniques Universitaires Saint-Luc, 1200 Brussels, Belgium
| | - Laurence Guignat
- Department of Endocrinology and National Reference Center for Rare Adrenal Disorders, Hôpital Cochin, Assistance publique-Hôpitaux de Paris, Paris, France
| | - Aude Brac de la Perrière
- Department of Paediatric Endocrinology, Angers University Hospital, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Angers, France
| | - Philippe Salva
- Patient National Association "Craniopharyngiome Solidarité", Tarbes, France
| | - Didier Scavarda
- Department of Neurosurgery, Hôpital La Timone Enfants, Marseille, France
| | - Fabrice Bonneville
- Department of Neuroradiology, University Hospital of Toulouse, CHU Purpan, 31000 Toulouse, France
| | - Philippe Caron
- Department of Endocrinology, Hôpital Larrey, CHU de Toulouse, 31059 Toulouse cedex 9, France
| | - Alexandre Vasiljevic
- Pathology and Neuropathology Department, Groupement Hospitalier Est, Hospices Civils de Lyon, Inserm U1052, CNRS UMR5286, Cancer Research Center of Lyon, Claude-Bernard Lyon 1 University, Bron, France
| | | | - Christine Cortet
- University of Lille, CHU de Lille, Department of Endocrinology, Diabetology, and Metabolism, U1190 Translational Research for Diabetes, Inserm, Institut Pasteur de Lille, Lille, France
| | - Stephan Gaillard
- Department of Neurosurgery, AP-HP, La Pitié-Salpêtrière University Hospital, Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France
| | - Frédérique Albarel
- AP-HM, Department of Endocrinology, Hôpital de la Conception, Centre de Référence des Maladies Rares de l'Hypophyse HYPO, Aix-Marseille Université, Inserm, U1251, Marseille Medical Genetics (MMG), Institut Marseille Maladies Rares (MarMaRa), 13005 Marseille, France
| | - Karine Clément
- Service de Nutrition, hôpital de la Pitié-Salpêtrière, AP-HP, Sorbonne Université, Inserm, Unité Nutrition et Obésités, approches systémiques, Nutriomique, 75013 Paris, France
| | - Emmanuel Jouanneau
- Adult Cranial Surgery Unit Skull Base and Pituitary Surgery Reference Centre for Rare Pituitary Diseases HYPO, Reference Center for type 2 Neurofibromatosis, Claude-Bernard University, Lyon, France, "Groupement Hospitalier Est" Hospices Civils de Lyon, Bron, France
| | - Henry Dufour
- Aix-Marseille Université, Inserm, AP-HM, MMG, UMR1251, Marmara Institute, La Timone Hospital, Hospital, Neurosurgery Department, Marseille, France
| | - Pascal Barat
- Pediatric Endocrinology Unit, CHU de Bordeaux, NutriNeurO, UMR, University of Bordeaux, Bordeaux, France
| | - Blandine Gatta-Cherifi
- Department of Endocrinology, CHU Bordeaux, Hôpital Haut Lévêque, Neurocentre Magendie, Physiopathologie de la Plasticité Neuronale, Université de Bordeaux, Pessac, France
| |
Collapse
|
4
|
Shin DW, Yee GT. Skull base reconstruction using hydroxyapatite and nasoseptal flap versus nasoseptal flap alone: meta-analysis and systematic review. Sci Rep 2024; 14:28433. [PMID: 39558022 PMCID: PMC11574179 DOI: 10.1038/s41598-024-79956-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2024] [Accepted: 11/13/2024] [Indexed: 11/20/2024] Open
Abstract
Endoscopic endonasal surgery (EES) is widely employed for interventions in skull base. Despite advancements in surgical techniques, cerebrospinal fluid (CSF) leakage remains a significant concern. The introduction of nasoseptal flap (NSF) dramatically reduced the CSF leakage rates, yet reconstruction techniques continue to vary among institutions and lack standardization. Recently, injectable hydroxyapatite (HA), traditionally used in open skull base reconstruction, has been adapted for use in EES. This study compares the effectiveness of HA and NSF reconstruction with the standard multilayer NSF reconstruction alone. We searched for eligible studies in PubMed, Embase, and Cochrane Library. CSF leakage rates and reconstruction-associated complication rates were thoroughly evaluated. We initially reviewed 3650 records, narrowing down to 13 articles for full-text examination. Of these, 3 retrospective cohort studies met our inclusion criteria, comparing outcomes of HA combined with NSF to NSF alone. The HA plus NSF group tended to exhibit lower rates of CSF leakage compared to the NSF alone group. Similarly, the rate of reconstruction-associated complication was also lower in the HA plus NSF group than in the control group. Skull base reconstruction using HA and NSF can be an effective way to minimize CSF leakage without major complications.
Collapse
Affiliation(s)
- Dong-Won Shin
- Department of Neurosurgery, Gachon University Gil Medical Center, University of Gachon College of Medicine, 783, Namdong-daero, Namdong-gu,, Incheon, Republic of Korea.
| | - Gi-Taek Yee
- Department of Neurosurgery, Gachon University Gil Medical Center, University of Gachon College of Medicine, 783, Namdong-daero, Namdong-gu,, Incheon, Republic of Korea
| |
Collapse
|
5
|
Wei W, Yan B, Zhang Q, Qi Y, Ren Q, Wang L, Liu J, Yang X, Wang Z. Endoscopic Endonasal Reconstruction of Intraoperative Cerebrospinal Fluid Leak in Different Skull Base Regions: Outcomes, Meningitis, and Risk Factors. World Neurosurg 2024; 189:e736-e744. [PMID: 38964462 DOI: 10.1016/j.wneu.2024.06.158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2024] [Revised: 06/27/2024] [Accepted: 06/28/2024] [Indexed: 07/06/2024]
Abstract
OBJECTIVES Various nonvascularized or vascularized techniques have been adopted in endoscopic endonasal surgery (EES) for repairing intraoperative cerebrospinal fluid (CSF) leaks after tumor resection. Vascularized nasoseptal flaps, free nasoseptal grafts, free turbinate grafts, and fascia lata and mashed muscle are frequently used. Outcomes of those grafts applied in the defects of different regions need to be clarified. METHODS The data from a series of 162 patients with skull base tumor who underwent EES that had intraoperative CSF leak between Jan 2012 and Jan 2021 were retrospectively analyzed. The regions included anterior skull base, sellar region, clivus and infratemporal fossa. Repair failure rate (RFR), meningitis rate, and associated risk factors were assessed. RESULTS In total, 172 reconstructions were performed in 162 patients for the 4 sites of the skull base. There were 7 cases (4.3%) that had postoperative CSF leaks, which required second repair. The RFR for anterior skull base, sellar region, clivus, and infratemporal fossawas 2.6%, 2.2%, 16.7%, and 0%, respectively. The clivus defect was an independent risk factor for repair failure (P < 0.01). The postoperative meningitis rate was 5.6%. Repair failure was an independent risk factor for meningitis (P < 0.01). CONCLUSIONS Vascularized nasoseptal flap, free nasoseptal graft, free turbinate graft, and fascia lata and mashed muscle are reliable autologous materials for repairing the dural defects in different regions during EES. Clivus reconstruction remains a great challenge, which had a higher RFR and meningitis rate. Repair failure is significantly associated with postoperative meningitis.
Collapse
Affiliation(s)
- Wei Wei
- Departments of Otorhinolaryngology-Head and Neck Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Bo Yan
- Departments of Otorhinolaryngology-Head and Neck Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Qiuhang Zhang
- Departments of Otorhinolaryngology-Head and Neck Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Yan Qi
- Departments of Otorhinolaryngology-Head and Neck Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Qinzhan Ren
- Departments of Otorhinolaryngology-Head and Neck Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Li Wang
- Departments of Otorhinolaryngology-Head and Neck Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Junqi Liu
- Departments of Otorhinolaryngology-Head and Neck Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Xiaotong Yang
- Departments of Otorhinolaryngology-Head and Neck Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China
| | - Zhenlin Wang
- Departments of Otorhinolaryngology-Head and Neck Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
| |
Collapse
|
6
|
Desai R, Kapur Z, Hammond B, Dombaxe CP, Chavez-Herrera VR, Tabaee A, Anand VK, Kacker A, Schwartz TH. Safety and efficacy of hydroset cranioplasty as an adjunct to gasket-seal and nasoseptal flap closure of the skull base. A case-controlled study. Acta Neurochir (Wien) 2024; 166:256. [PMID: 38850489 DOI: 10.1007/s00701-024-06134-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2024] [Accepted: 05/20/2024] [Indexed: 06/10/2024]
Abstract
BACKGROUND Cerebrospinal fluid leak after endoscopic skull base surgery remains a significant complication. Several investigators have suggested Hydroset cranioplasty to reduce leak rates. We investigated our early experience with Hydroset and compared the rate of nasal complications and CSF leak rates with case-controlled historic controls. METHODS We queried a prospective database of patients undergoing first time endoscopic, endonasal resection of suprasellar meningiomas and craniopharyngiomas from 2015 to 2023. We compared cases closed with a gasket seal, Hydroset, and a nasoseptal flap with those closed with only a gasket seal and nasoseptal flap. Demographics, technical considerations and postoperative outcomes (SNOT-22) were compared. RESULTS Seventy patients met inclusion criteria, twenty patients in the Hydroset group (meningioma n = 12; craniopharyngioma n = 8) and 50 control patients (meningioma n = 25; craniopharyngioma n = 25). CSF diversion was used in fewer Hydroset patients (75%, 15/20) compared with control group (94%, 47/50; p = 0.02). CSF leak was less frequent in the Hydroset than the control group (5% versus 12%, p = 0.38). One Hydroset patient required delayed nasal debridement. SNOT-22 responses demonstrated no significant difference in sinonasal complaints between groups (Hydroset average SNOT-22 score 22.45, control average SNOT-22 score 25.90; p = 0.58). CONCLUSIONS We demonstrate that hydroxyapatite reconstruction leads to improved CSF leak control above that provided by the gasket-seal and nasoseptal flap, without significant associated morbidity as long as the cement is fully covered with vascularized tissue.
Collapse
Affiliation(s)
- Rupen Desai
- Department of Neurological Surgery, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY, USA
| | - Zoe Kapur
- Department of Neurological Surgery, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY, USA
| | - Benjamin Hammond
- Department of Neurological Surgery, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY, USA
| | - Cátia P Dombaxe
- Department of Neurological Surgery, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY, USA
| | | | - Abtin Tabaee
- Department of Otolaryngology-Head and Neck Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA
| | - Vijay K Anand
- Department of Otolaryngology-Head and Neck Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA
| | - Ashutosh Kacker
- Department of Otolaryngology-Head and Neck Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA
| | - Theodore H Schwartz
- Department of Neurological Surgery, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY, USA.
- Department of Otolaryngology-Head and Neck Surgery, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA.
| |
Collapse
|
7
|
Hong I, Kim KH, Seo Y, Choo YH, Lee HJ, Kim SH. Efficacy of hydroxyapatite-based skull base reconstruction for intraoperative high-flow cerebrospinal fluid leakage performed by less-experienced surgeons. Sci Rep 2023; 13:14886. [PMID: 37689766 PMCID: PMC10492792 DOI: 10.1038/s41598-023-42097-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2023] [Accepted: 09/05/2023] [Indexed: 09/11/2023] Open
Abstract
Cerebrospinal fluid (CSF) leakage after endoscopic skull base surgery remains a challenge despite multilayer reconstruction including nasoseptal flap (NSF) has become a standard technique. Injectable hydroxyapatite (HXA) has shown promising results to prevent CSF leakage. This study aimed to validate the efficacy of HXA-based skull base reconstruction performed by less-experienced neurosurgeons who had short-term clinical experiences as independent surgeons. Between March 2018 and November 2022, 41 patients who experienced intraoperative high-flow CSF leakage following endoscopic endonasal surgery at two independent tertiary institutions were enrolled. Skull base reconstruction was performed using conventional multilayer techniques combined with or without HXA. The primary outcome was postoperative CSF leakage. The surgical steps and nuances were described in detail. The most common pathology was craniopharyngioma. Injectable HXA was used in 22 patients (HXA group) and conventional techniques were performed in 19 patients (control group). The HXA group achieved a significantly lower incidence of postoperative CSF leakage than the control group (0% vs. 26.3%, p = 0.016). No HXA-related complications were observed. The use of injectable HXA in skull base reconstruction was highly effective and safe. This technique and its favorable results might be readily reproduced by less-experienced neurosurgeons.
Collapse
Affiliation(s)
- Inseo Hong
- Department of Neurosurgery, Chungnam National University Hospital, Chungnam National University School of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon, 35015, South Korea
| | - Kyung Hwan Kim
- Department of Neurosurgery, Chungnam National University Hospital, Chungnam National University School of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon, 35015, South Korea.
| | - Youngbeom Seo
- Department of Neurosurgery, Yeungnam University Hospital, Yeungnam University College of Medicine, Daegu, South Korea
| | - Yoon-Hee Choo
- Department of Neurosurgery, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, South Korea
| | - Han-Joo Lee
- Department of Neurosurgery, Chungnam National University Hospital, Chungnam National University School of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon, 35015, South Korea
| | - Seon-Hwan Kim
- Department of Neurosurgery, Chungnam National University Hospital, Chungnam National University School of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon, 35015, South Korea
| |
Collapse
|
8
|
Tosi U, Ramos A, Rampichini M, Alexiades G, Boddu S, Cisse B, Kacker A, Patsalides A, Tabaee A, Schwarz J, Schwartz TH, Ramakrishna R. Combined surgical repair and venous sinus stenting for patients with skull base encephaloceles secondary to dural venous sinus stenosis. Acta Neurochir (Wien) 2023; 165:2283-2292. [PMID: 37344735 DOI: 10.1007/s00701-023-05680-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2023] [Accepted: 06/09/2023] [Indexed: 06/23/2023]
Abstract
BACKGROUND Chronically elevated intracranial pressure (ICP) seen in idiopathic intracranial hypertension (IIH) can cause the development of skull base encephaloceles and cerebrospinal fluid (CSF) leaks. Surgical repair and ventriculoperitoneal shunt (VPS) placement are mainstays of treatment. Venous sinus stenting (VSS) is a newly accepted treatment modality. The goal of this study was thus to determine if VSS can be used to treat symptoms and prevent recurrence after surgical encephalocele repair. METHODS Retrospective chart review of patients that had surgical repair of encephaloceles followed by VSS for symptomatic stenosis with elevated pressure gradient. RESULTS A total of 13 patients underwent a combined encephalocele repair and VSS. Seventy-two percent were female; 46% had headaches, 69% pulsatile tinnitus, and 92% CSF rhinorrhea or otorrhea. One had seizures. Mean lumbar opening pressure was 23.3 ± 2.6 cm H2O; the average sagittal-to-jugular pressure gradient was 12.7 ± 1.8 cmH2O and was elevated in all patients. Four patients had middle fossa craniotomy for repair of tegmen defect (one bilateral); one had a retrosigmoid craniotomy for repair of a sigmoid plate defect. Eight had an endoscopic endonasal repair for sphenoid or cribriform plate encephalocele. There were no VSS procedural complications or complications associated with dual antiplatelet therapy. One patient had meningitis after endoscopic repair that was treated with antibiotics. One patient had recurrence of both CSF leak and venous stenosis adjacent to the stent requiring repeat repair and VSS. There was no further recurrence. CONCLUSION In patients with dural sinus stenosis and encephaloceles requiring repair, VSS can be performed safely within weeks of surgery for relief of symptoms, resolution of underlying pathology, and prevention of CSF leak recurrence.
Collapse
Affiliation(s)
- Umberto Tosi
- Department of Neurological Surgery, NewYork-Presbyterian, Weill Cornell Medicine, 525 E 68th St, Box 99, New York, NY, 10065, USA
| | - Alexander Ramos
- Department of Neurological Surgery, NewYork-Presbyterian, Weill Cornell Medicine, 525 E 68th St, Box 99, New York, NY, 10065, USA
| | - Margherita Rampichini
- Department of Neurological Surgery, NewYork-Presbyterian, Weill Cornell Medicine, 525 E 68th St, Box 99, New York, NY, 10065, USA
| | - George Alexiades
- Department of Otolaryngology, NewYork-Presbyterian, Weill Cornell Medicine, New York, NY, USA
| | - Srikanth Boddu
- Department of Neurological Surgery, NewYork-Presbyterian, Weill Cornell Medicine, 525 E 68th St, Box 99, New York, NY, 10065, USA
| | - Babacar Cisse
- Department of Neurological Surgery, NewYork-Presbyterian, Weill Cornell Medicine, 525 E 68th St, Box 99, New York, NY, 10065, USA
| | - Ashutosh Kacker
- Department of Otolaryngology, NewYork-Presbyterian, Weill Cornell Medicine, New York, NY, USA
| | - Athos Patsalides
- Department of Neurological Surgery, NewYork-Presbyterian, Weill Cornell Medicine, 525 E 68th St, Box 99, New York, NY, 10065, USA
| | - Abtin Tabaee
- Department of Otolaryngology, NewYork-Presbyterian, Weill Cornell Medicine, New York, NY, USA
| | - Justin Schwarz
- Department of Neurological Surgery, NewYork-Presbyterian, Weill Cornell Medicine, 525 E 68th St, Box 99, New York, NY, 10065, USA
| | - Theodore H Schwartz
- Department of Neurological Surgery, NewYork-Presbyterian, Weill Cornell Medicine, 525 E 68th St, Box 99, New York, NY, 10065, USA
- Department of Otolaryngology, NewYork-Presbyterian, Weill Cornell Medicine, New York, NY, USA
| | - Rohan Ramakrishna
- Department of Neurological Surgery, NewYork-Presbyterian, Weill Cornell Medicine, 525 E 68th St, Box 99, New York, NY, 10065, USA.
| |
Collapse
|
9
|
Kwon TH, Shin HK, Yoon WK, Kim JH, Byun J. Antibiotics Prophylaxis for Endoscopic Endonasal Approach for Skull Base Tumor Surgery: A Meta-Analysis. World Neurosurg 2023; 174:e82-e91. [PMID: 36894007 DOI: 10.1016/j.wneu.2023.02.143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2023] [Revised: 02/27/2023] [Accepted: 02/28/2023] [Indexed: 03/09/2023]
Abstract
BACKGROUND The regimen of prophylactic antibiotic for endoscopic endonasal skull base surgery (EE-SBS) varies considerably depending on surgeons and their institutes. The purpose of the present meta-analysis is to assess the effect of antibiotic regimens on EE-SBS surgery for anterior skull base tumor. METHODS The PubMed, Embase, Web of Science, and Cochrane clinical trial databases were systematically searched through October 15, 2022. RESULTS The 20 included studies were all retrospective. The studies included a total of 10,735 patients who underwent EE-SBS for skull base tumor. The proportion of patients with postoperative intracranial infection across all 20 studies was 0.9% (95% confidence interval [CI] 0.5%-1.3%). The proportion of postoperative intracranial infection in the multiple antibiotics group did not show statistically significant difference to that of the single antibiotic agent group (proportion: 0.6%, 95% CI 0%-1.4% vs. proportion: 1%, 95% CI 0.6%-1.5%, respectively, P = 0.39). The ultra-short duration maintenance group showed lower incidence of postoperative intracranial infection, although it did not reach statistical significance (ultra-short group: 0.7%, 95% CI 0.5%-0.9%; short duration: 1.8%, 95% CI 0.5%-3%; and long duration: 1%, 95% CI 0.2%-1.9%, P = 0.22) The combination of the multiple antibiotics group did not show meaningful low incidence of postoperative intracranial infection (antibiotics combination group: 0.6%, 95% CI 0%-1.4%; cefazolin single group: 0.8%, 95% CI 0%-1.6%; and single antibiotics other than cefazolin: 1.2%, 95% CI 0.7%-1.7%, P = 0.22). CONCLUSIONS Multiple antibiotics did not show superiority compared with single antibiotic agent. Also, long maintenance duration of antibiotics did not reduce the incidence of postoperative intracranial infection.
Collapse
Affiliation(s)
- Taek Hyun Kwon
- Department of Neurosurgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
| | - Hong Kyung Shin
- Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - Won Ki Yoon
- Department of Neurosurgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
| | - Jong Hyun Kim
- Department of Neurosurgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
| | - Joonho Byun
- Department of Neurosurgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
| |
Collapse
|
10
|
Baussart B, Venier A, Jouinot A, Reuter G, Gaillard S. Closure strategy for endoscopic pituitary surgery: Experience from 3015 patients. Front Oncol 2023; 12:1067312. [PMID: 36686774 PMCID: PMC9846073 DOI: 10.3389/fonc.2022.1067312] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2022] [Accepted: 12/05/2022] [Indexed: 01/05/2023] Open
Abstract
Introduction Effective strategies are required to ensure optimal management of the crucial closure step in endoscopic pituitary surgery. Many surgical techniques have been reported but no significant consensus has been defined. Methods Between January 2006 and March 2022, 3015 adult patients with pituitary adenomas were operated on by a single expert neurosurgical team, using a mononostril endoscopic endonasal approach. Based of preoperative risk factors of and operative findings, a detailed closure strategy was used. Body mass index >40, sellar floor lysis, number of surgeries>2, large skull base destruction, prior radiotherapy were considered as preoperative risk factors for closure failure. All patients treated with an expanded endonasal approach were excluded. Results Patients were mostly women (F/M ratio: 1.4) with a median age of 50 (range: 18 -89). Intraoperative CSF leak requiring specific surgical management was observed in 319/3015 (10.6%) of patients. If intraoperative leak occurred, patients with predictive risk factors were managed using a Foley balloon catheter in case of sellar floor lysis or BMI>40 and a multilayer repair strategy with a vascularized nasoseptal flap in other cases. Postoperative CSF leak occurred in 29/3015 (1%) of patients, while meningitis occurred in 24/3015 (0.8%) of patients. In patients with intraoperative leak, closure management failed in 11/319 (3.4%) of cases. Conclusion Based on our significant 16-year experience, our surgical management is reliable and easy to follow. With a planned and stepwise strategy, the closure step can be optimized and tailored to each patient with a very low failure rate.
Collapse
Affiliation(s)
- Bertrand Baussart
- Department of Neurosurgery, La Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France,Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France,*Correspondence: Bertrand Baussart, ;
| | - Alice Venier
- Department of Neurosurgery, Neurocenter of Southern Switzerland, Lugano, Switzerland
| | - Anne Jouinot
- Université Paris Cité, Institut Cochin, CNRS, INSERM, Paris, France
| | - Gilles Reuter
- Department of Neurosurgery, Centre Hospitalier Universitaire (CHU) de Liège, Bat B35, Domaine Universitaire du Sart-Tilman, Liège, Belgium
| | - Stephan Gaillard
- Department of Neurosurgery, La Pitié-Salpêtrière University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| |
Collapse
|
11
|
Zhou Y, Wei J, Jin T, Hei Y, Jia P, Lin J, Yang S, Jiang X, Liu W, Gao D. Extended endoscopic endonasal approach for resecting anterior intrinsic third ventricular craniopharyngioma. Front Oncol 2022; 12:998683. [PMID: 36248957 PMCID: PMC9562125 DOI: 10.3389/fonc.2022.998683] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2022] [Accepted: 09/05/2022] [Indexed: 12/02/2022] Open
Abstract
Background The surgical treatment of the extended endoscopic endonasal approach (EEEA) is a safe and effective treatment for suprasellar craniopharyngiomas. However, due to damage to the hypothalamus and third ventricle floor (TVF), EEEA is generally regarded as unsuitable in treating intrinsic third ventricle craniopharyngioma (ITVC) that is entirely within the third ventricle. Until now, there have been only a small number of reports using EEEA to treat TVC via a supra-infrachiasmatic approach. Given that the translamina terminalis (TLT) corridor was used in the transcranial subfrontal approach, EEEA via a suprachiasmatic approach may be feasible and practical to treat ITVC. In the current study, we accumulated experience applying the suprachiasmatic translamina terminalis (STLT) corridor for anterior treatment of ITVC. Methods From March 2016 to December 2020, 14 patients with ITVC in our center were analyzed retrospectively. All patients underwent surgery by EEEA via an STLT corridor. The multilayer reconstruction technique was adopted to achieve skull base reconstruction. Data concerning the patient’s tumor resection, vision, hypophyseal hormone, and complications were collected. Results Gross-total resection was achieved in 13 (92.8%) of14 patients, with achievement of near-total (90%) resection in the remaining 1 patient. Nine cases (64.3%) were papillary craniopharyngiomas, and the other 5 cases were adamantinomatous subtypes. Postoperatively, 3 patients with pituitary insufficiency received hormone replacement therapy. No permanent diabetes insipidus or hypothalamic obesity was found. All pairs showed significant improvement or stability in vision except 1 patient who encountered visual deterioration. No other neurological deficit occurred postoperatively. Observation results for the exudation of nasal tissue and the length of hospitalization were satisfactory. After a mean follow-up period of 26.2 months, tumor recurrence was not observed. Conclusion TLT is a minimally invasive corridor used in EEEA for treating anterior ITVC without increasing risks of visual and hormonal deficits. The multilayered reconstruction technique we used is a safe and effective method for achieving watertight closure and avoiding cerebrospinal fluid leaks and infection. The endonasal approach via STLT provides a new, safe and efficacious operative strategy that should be considered a surgical alternative in treating ITVC.
Collapse
Affiliation(s)
- Yuefei Zhou
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China
| | - Jialiang Wei
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China
- Department of Health Service, Fourth Military Medical University, Xi’an, China
| | - Tao Jin
- Department of Neurosurgery, An Kang Center Hospital, An Kang, China
| | - Yue Hei
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China
| | - Pengfei Jia
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China
| | - Jincai Lin
- Department of Neurosurgery, Mao Ming People’s Hospital, Mao Ming, China
| | - Shuangwu Yang
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China
| | - Xiaofan Jiang
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China
| | - Weiping Liu
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China
| | - Dakuan Gao
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China
- *Correspondence: Dakuan Gao,
| |
Collapse
|
12
|
Lee SH, Ha CM, Hong SD, Choi JW, Seol HJ, Nam DH, Lee JI, Kong DS. Clinical Impact of Hydroxyapatite on the Outcome of Skull Base Reconstruction for Intraoperative High-Flow CSF Leak: A Propensity Score Matching Analysis. Front Oncol 2022; 12:906162. [PMID: 35600408 PMCID: PMC9116718 DOI: 10.3389/fonc.2022.906162] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Accepted: 04/14/2022] [Indexed: 11/24/2022] Open
Abstract
Background Despite recent advances in skull base reconstructive techniques, including the multilayer technique during the last decade, complete reconstruction of grade 3 intraoperative high-flow cerebrospinal fluid (CSF) leak remains challenging. This study was designed to investigate the role of injectable hydroxyapatite (HXA) used in the multilayer technique on the clinical outcome of skull base reconstruction for intraoperative high-flow CSF leak. Materials and Methods This study enrolled 187 patients who experienced intraoperative high-flow CSF leak after endoscopic endonasal surgery for anterior skull base or suprasellar pathologies between January 2014 and July 2021. All skull base defects were reconstructed using the conventional multilayer technique including a vascularized naso-septal flap (NSF, n = 141) and the combined use of HXA with the conventional multilayer technique (HXA group, n = 46). We retrospectively evaluated the efficacy of the HXA group by 1:2 propensity score matching analysis. Results Overall, 17 of 187 patients (9.1%) showed postoperative CSF leaks, resulting in second reconstruction surgery. There were no statistical differences in patient age, sex, body mass index, tumor location, tumor type, and degree of resection, except for the follow-up period between the two groups. The HXA group showed a significantly lower incidence of postoperative CSF leak than the control group (0% vs. 12.1%, p < 0.05). Postoperative lumbar drain (LD) was performed in 8.7% of the HXA group compared to 46.1% of the control group (p < 0.01). CSF leak-related infection rates showed a decreasing tendency in the HXA group compared to the control group (0 vs. 7.1%, p = 0.06). A total of 46 patients in the HXA group were well matched with the control group (92 patients) at a 1:2 ratio. In the propensity score-matched control group, there were higher rates of postoperative CSF leaks than in the HXA group. Conclusion The use of HXA combined with the conventional multilayer technique completely reduced postoperative CSF leaks in this study. This technique resulted in reduced CSF leakage, even without postoperative LD, and decreased infection rates. Further randomized comparative studies are required to confirm our findings.
Collapse
Affiliation(s)
- Shin Heon Lee
- Department of Neurosurgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea
| | - Chang-Min Ha
- Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Sang Duk Hong
- Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Jung Won Choi
- Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Ho Jun Seol
- Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Do-Hyun Nam
- Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Jung-Il Lee
- Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| | - Doo-Sik Kong
- Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
| |
Collapse
|